Skip to main content
Title Pub Year Author SearchLink Sort descending
Tobacco and alcohol consumption among 11- to 17-year-old adolescents: results of the KiGGS study: first follow-up (KiGGS Wave 1) 2014 Abteilung fur Epidemiologie und Gesundheitsmonitoring, Robert Koch-Institut, General-Pape-Strasse 62-64, 12101, Berlin, Deutschland, t.lampert@rki.de.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Periodical, Abbrev.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Pub Date Free Form
Jul
Volume
57
Issue
7
Start Page
830
Other Pages
839
Notes
LR: 20160707; JID: 101181368; ppublish
Place of Publication
Germany
ISSN/ISBN
1437-1588; 1436-9990
Accession Number
PMID: 24950832
Language
ger
SubFile
English Abstract; Journal Article; IM
DOI
10.1007/s00103-014-1982-8 [doi]
Output Language
Unknown(0)
PMID
24950832
Abstract
In this paper, tobacco and alcohol consumption among adolescents in Germany was analyzed. In addition to the current situation, we report temporal developments and trends. Data were obtained from the first follow-up of the KiGGS study (KiGGS Wave 1) conducted from 2009 to 2012. All girls and boys aged 11-17 years (n = 5,258) were included. The results show that currently 12.0% of 11- to 17-year-old adolescents in Germany smoke, 5.4% of them on a daily basis. At-risk drinking (AUDIT-C total score) was prevalent among 15.8% of adolescents, heavy episodic drinking (six or more alcoholic standard drinks on a single occasion at least once a month) among 11.5%. No significant gender differences were found for most indicators. However, among adolescents aged 14-17 years, boys revealed a greater inclination toward heavy episodic drinking than girls did (23.1 vs. 16.5 %, p
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Lampert,T., Kuntz,B., KiGGS Study Group
Original/Translated Title
Tabak- und Alkoholkonsum bei 11- bis 17-jahrigen Jugendlichen : Ergebnisse der KiGGS-Studie - Erste Folgebefragung (KiGGS Welle 1)
URL
Date of Electronic
PMCID
Editors
HPV vaccination coverage in German girls: results of the KiGGS study: first follow-up (KiGGS Wave 1) 2014 Abteilung fur Epidemiologie und Gesundheitsmonitoring, Robert Koch-Institut, General-Pape-Strasse 62-66, 12101, Berlin, Deutschland, poethko-muellerc@rki.de.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Periodical, Abbrev.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Pub Date Free Form
Jul
Volume
57
Issue
7
Start Page
869
Other Pages
877
Notes
LR: 20160707; JID: 101181368; 0 (Papillomavirus Vaccines); ppublish
Place of Publication
Germany
ISSN/ISBN
1437-1588; 1436-9990
Accession Number
PMID: 24950836
Language
ger
SubFile
English Abstract; Journal Article; IM
DOI
10.1007/s00103-014-1987-3 [doi]
Output Language
Unknown(0)
PMID
24950836
Abstract
OBJECTIVES: In Germany, vaccination against HPV infection has been recommended for girls aged 12-17 years since 2007. The aim of this paper was to provide an overview of the current status and determinants of HPV vaccination uptake in Germany. METHODS: Analyses included data from 14- to 17-year-old girls (n =1,337) of the German Health Interview and Examination Survey for Children and Adolescents - First Follow-up Survey (KiGGS Wave 1). Standardized telephone interviews included questions for girls on the number of HPV vaccine doses and visits to a gynecologist. Parents were asked about their socioeconomic status (SES) and the girls' participation in the J1 adolescent health check-up. Descriptive analyses of the HPV vaccination status with respect to social, demographic, and health-care utilization factors were performed. Factors associated with vaccination were identified and odds ratios (OR) were estimated by means of logistic regression analysis. RESULTS: The prevalence of vaccination with at least one HPV vaccine dose was 52.6% (95% confidence interval 48.5-56.6). Three-dose HPV vaccination coverage was 39.5% (35.3-43.9). Vaccine uptake increased with age, was higher in girls with middle and low SES compared with high SES, with residence in eastern Germany, in those who had already seen a gynecologist, and who participated in the J1. Multivariable logistic regression revealed a twofold increased chance of being vaccinated for girls with middle SES (OR 1.9) compared with high-SES girls and for those who had yet seen a gynecologist (OR 2.1). CONCLUSIONS: School-based vaccination programs and multi-tier vaccination campaigns have led to high vaccination rates in some European and non-European countries. In Germany, however, such high vaccination rates have not been achieved. To fully realize the potential of HPV vaccinations to reduce HPV-related cancer incidence at the population level, vaccination coverage in Germany must be increased. In absence of school-based vaccination programs, medical doctors should use each visit to check and complete the girl's vaccination status.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Poethko-Muller,C., Buttmann-Schweiger,N., KiGGS Study Group
Original/Translated Title
Impfstatus und Determinanten der Impfung gegen humane Papillomviren (HPV) bei Madchen in Deutschland : Ergebnisse der KiGGS-Studie - Erste Folgebefragung (KiGGS Welle 1)
URL
Date of Electronic
PMCID
Editors
Cigarette users' interest in using or switching to electronic nicotine delivery systems for smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of US adults 2015 Department of Behavioral Sciences and Health Education, Emory University Rollins School of Public Health, Atlanta, GA; cjberg@emory.edu.; Department of Behavioral Sciences and Health Education, Emory University Rollins School of Public Health, Atlanta, GA
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Periodical, Abbrev.
Nicotine Tob.Res.
Pub Date Free Form
Feb
Volume
17
Issue
2
Start Page
245
Other Pages
255
Notes
LR: 20160202; CI: (c) The Author 2014; GR: 1K07CA139114-01A1/CA/NCI NIH HHS/United States; GR: 3 U48 DP001909-04S1/DP/NCCDPHP CDC HHS/United States; GR: K07 CA139114/CA/NCI NIH HHS/United States; GR: U01 CA154282/CA/NCI NIH HHS/United States; GR: U01CA154
Place of Publication
England
ISSN/ISBN
1469-994X; 1462-2203
Accession Number
PMID: 24951496
Language
eng
SubFile
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; IM
DOI
10.1093/ntr/ntu103 [doi]
Output Language
Unknown(0)
PMID
24951496
Abstract
INTRODUCTION: We examined: (a) current (past 30-day) smokers' interest in using or switching to electronic nicotine delivery systems (ENDS) or smokeless tobacco for various reasons; (b) correlates of interest in these products; and (c) subgroups of current smokers in relation to interest in these products. METHODS: We conducted a cross-sectional survey assessing sociodemographics, tobacco use, interest in ENDS and smokeless tobacco among smokers, and knowledge about ENDS among 2,501 US adults recruited through an online consumer panel. We oversampled tobacco users (36.7% current cigarette smokers), ethnic minorities, and southeastern US state residents. RESULTS: On average, participants were more interested in ENDS than smokeless tobacco across all reasons provided. Additionally, they were less interested in either product because of their potential use in places prohibiting smoking or due to curiosity and more interested in reducing health risk or cigarette consumption or to aid in cessation. We documented high rates (27.9%) of misbeliefs about Food and Drug Administration approval of ENDS for cessation, particularly among current smokers (38.5%). Also, 27.2% of current smokers had talked with a health care provider about ENDS, with 18.0% reporting that their provider endorsed ENDS use for cessation. Furthermore, cluster analyses revealed 3 groups distinct in their interest in the products, sociodemographics, and smoking-related characteristics. CONCLUSIONS: This study highlights higher interest in ENDS versus smokeless tobacco and greater interest in both for harm reduction and cessation than due to novelty or smoking restrictions. Developing educational campaigns and informing practitioners about caveats around ENDS as cessation or harm reduction aids are critical.
Descriptors
Links
Book Title
Database
Publisher
. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco
Data Source
Authors
Berg,C.J., Haardoerfer,R., Escoffery,C., Zheng,P., Kegler,M.
Original/Translated Title
URL
Date of Electronic
20140620
PMCID
PMC4311172
Editors
Cerebellar infarction presenting as inner ear decompression sickness following scuba diving: a case report 2014 Service de medecine hyperbare et expertise plongee, hopital d'instruction des Armees Sainte-Anne, BP 600, 83800 Toulon cedex 9, France. Electronic address: gempp@voila.fr.; Service de medecine hyperbare et expertise plongee, hopital d'instruction des Arme
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
European annals of otorhinolaryngology, head and neck diseases
Periodical, Abbrev.
Eur.Ann.Otorhinolaryngol.Head.Neck.Dis.
Pub Date Free Form
Nov
Volume
131
Issue
5
Start Page
313
Other Pages
315
Notes
CI: Copyright (c) 2014; JID: 101531465; OTO: NOTNLM; 2013/03/05 [received]; 2013/04/10 [revised]; 2013/06/09 [accepted]; 2014/06/18 [aheadofprint]; ppublish
Place of Publication
France
ISSN/ISBN
1879-730X; 1879-7296
Accession Number
PMID: 24954030
Language
eng
SubFile
Case Reports; Journal Article; IM
DOI
10.1016/j.anorl.2013.06.005 [doi]
Output Language
Unknown(0)
PMID
24954030
Abstract
INTRODUCTION: Inner ear decompression sickness following scuba diving is not uncommon and the characteristic features of this disorder are acute peripheral vestibular syndrome, sometimes associated with cochlear signs, requiring urgent hyperbaric oxygen therapy. Cerebellar infarction can also mimic isolated peripheral vestibulopathy. CASE REPORT: The authors report the case of a 47-year-old man in good general health admitted with acute left vestibular dysfunction suggestive of inner ear decompression sickness 6 hours after scuba diving. Normal videonystagmography and delayed onset of occipital headache finally led to brain MRI that confirmed the presence of recent ischaemic infarction in the territory of the medial branch of the posterior inferior cerebellar artery. Complementary investigations revealed the presence of a patent foramen ovale with atrial septal aneurysm. No underlying atherosclerotic disease or clotting abnormalities were observed. DISCUSSION/CONCLUSION: Cerebellar infarction can present clinically with features of inner ear decompression sickness following scuba diving. An underlying air embolism mechanism cannot be excluded, particularly in patients with a large right-to-left circulatory shunt and no other cardiovascular risk factors.
Descriptors
Links
Book Title
Database
Publisher
Elsevier Masson SAS
Data Source
Authors
Gempp,E., Louge,P., Soulier,B., Alla,P.
Original/Translated Title
URL
Date of Electronic
20140618
PMCID
Editors
An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States 2014 New York University Langone Medical Center, Department of Population Health , New York , USA.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Substance use & misuse
Periodical, Abbrev.
Subst.Use Misuse
Pub Date Free Form
Nov
Volume
49
Issue
13
Start Page
1774
Other Pages
1783
Notes
JID: 9602153; 0 (Street Drugs); KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine); OTO: NOTNLM; 2014/06/23 [aheadofprint]; ppublish
Place of Publication
England
ISSN/ISBN
1532-2491; 1082-6084
Accession Number
PMID: 24955818
Language
eng
SubFile
Journal Article; IM
DOI
10.3109/10826084.2014.926933 [doi]
Output Language
Unknown(0)
PMID
24955818
Abstract
BACKGROUND: Although ecstasy (MDMA) use is not as prevalent in the United States (US) as it was in the early 2000s, use remains popular among adolescents and young adults. Few recent studies have examined ecstasy use in national samples among those at particularly high risk for use-adolescents approaching adulthood. Research is needed to delineate sociodemographic correlates of use in this group. METHODS: Data were examined from a nationally representative sample of high school seniors in the US (modal age = 18) from the Monitoring the Future study (years 2007-2012; weighted N = 26,504). Data from all cohorts were aggregated and correlates of recent (last 12-month) use of ecstasy were examined. RESULTS: Roughly 4.4% of high school seniors reported use of ecstasy within the last year. Females and religious students were consistently at lower odds for use. Black and Hispanic students, and students residing with two parents, were at lower odds for ecstasy use, until controlling for other drug use. Odds of use were consistently increased for those residing in a city, students with weekly income of >$50 from a job, and students earning >$10 weekly from other sources. Lifetime use of alcohol, cigarettes, marijuana, and other illicit drugs each robustly increased odds of ecstasy use. CONCLUSION: Subgroups of high school seniors, defined by specific sociodemographic factors, and those who have used other drugs, are currently at high risk for ecstasy initiation and use. Since ecstasy is regaining popularity in the US, prevention efforts should consider these factors.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Palamar,J.J., Kamboukos,D.
Original/Translated Title
URL
Date of Electronic
20140623
PMCID
Editors
Promotion of waterpipe tobacco use, its variants and accessories in young adult newspapers: a content analysis of message portrayal 2015 Division of Health Promotion and Behavior, School of Public Health, Georgia State University, Atlanta, GA 30033, USA and Department of Behavioral and Community Health, School of Public Health, University of Maryland, College Park, MD 20742-2611, USA kster
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Health education research
Periodical, Abbrev.
Health Educ.Res.
Pub Date Free Form
Feb
Volume
30
Issue
1
Start Page
152
Other Pages
161
Notes
LR: 20160715; CI: (c) The Author 2014; GR: 1R03CA159909-01A1/CA/NCI NIH HHS/United States; GR: P20 MD006737/MD/NIMHD NIH HHS/United States; GR: R03 CA159909/CA/NCI NIH HHS/United States; GR: R21 CA180934/CA/NCI NIH HHS/United States; GR: R24 HD041041/HD/N
Place of Publication
England
ISSN/ISBN
1465-3648; 0268-1153
Accession Number
PMID: 24957675
Language
eng
SubFile
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; T
DOI
10.1093/her/cyu035 [doi]
Output Language
Unknown(0)
PMID
24957675
Abstract
The objective of our study was to identify waterpipe tobacco smoking advertisements and those that promoted a range of products and accessories used to smoke waterpipe tobacco. The content of these advertisements was analyzed to understand the messages portrayed about waterpipe tobacco smoking in young adult (aged 18-30) newspapers. The study methods include monitoring of six newspapers targeting young adults from four major cities in the Southeastern United States over a 6-month period. A total of 87 advertisements were found; 73.5% (64) were distinct and content analyzed. The study results showed that of the advertisements analyzed, 25% advertised waterpipe tobacco smoking, 54.7% featured waterpipe tobacco smoking and other tobacco use, 14.1% featured non-tobacco waterpipe variants (i.e. vaporizers), and 6.3% featured waterpipe apparatus accessories (e.g. charcoal, hoses). The sociability (34%) and sensuality (29.7%) of waterpipe smoking were promoted themes. Alternative to cigarette use messages (3.1%), and harm-reduction messages (17.1%) emphasized that smoking waterpipe tobacco using the featured accessory or waterpipe variant was a healthier experience than cigarette smoking. The study concluded that the messages that promoted waterpipe tobacco smoking to young adults are parallel to those used to promote cigarette use. Tobacco control professionals should continue to monitor young adult newspapers as a source of waterpipe-related advertising.
Descriptors
Links
Book Title
Database
Publisher
. Published by Oxford University Press
Data Source
Authors
Sterling,K.L., Fryer,C.S., Majeed,B., Duong,M.M.
Original/Translated Title
URL
Date of Electronic
20140623
PMCID
PMC4296886
Editors
Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms 2014 Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Maranon, Madrid, Spain Instituto de Investigacion Sanitaria Gregorio Maranon, Madrid, Spain mariaguembe@hotmail.com jguineaortega@yahoo.es.; Department of
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Antimicrobial Agents and Chemotherapy
Periodical, Abbrev.
Antimicrob.Agents Chemother.
Pub Date Free Form
Sep
Volume
58
Issue
9
Start Page
5581
Other Pages
5584
Notes
LR: 20150301; CI: Copyright (c) 2014; JID: 0315061; 0 (Antifungal Agents); 0 (Echinocandins); 0 (Lipopeptides); R10H71BSWG (micafungin); OID: NLM: PMC4135876; 2014/06/23 [aheadofprint]; ppublish
Place of Publication
United States
ISSN/ISBN
1098-6596; 0066-4804
Accession Number
PMID: 24957821
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; IM
DOI
10.1128/AAC.02738-14 [doi]
Output Language
Unknown(0)
PMID
24957821
Abstract
We assessed the in vitro activity of micafungin against preformed Candida biofilms by measuring the concentration of drug causing the most fungal damage and inhibition of regrowth. We studied 37 biofilm-producing Candida spp. strains from blood cultures. We showed that micafungin was active against planktonic and sessile forms of Candida albicans strains and moderately active against Candida parapsilosis sessile cells. Concentrations of micafungin above 2 mug/ml were sufficiently high to inactivate regrowth of Candida sessile cells.
Descriptors
Links
Book Title
Database
Publisher
American Society for Microbiology. All Rights Reserved
Data Source
Authors
Guembe,M., Guinea,J., Marcos-Zambrano,L.J., Fernandez-Cruz,A., Pelaez,T., Munoz,P., Bouza,E.
Original/Translated Title
URL
Date of Electronic
20140623
PMCID
PMC4135876
Editors
Tobacco product use among adults--United States, 2012-2013 2014
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
MMWR.Morbidity and mortality weekly report
Periodical, Abbrev.
MMWR Morb.Mortal.Wkly.Rep.
Pub Date Free Form
27-Jun
Volume
63
Issue
25
Start Page
542
Other Pages
547
Notes
LR: 20140819; JID: 7802429; EIN: MMWR Morb Mortal Wkly Rep. 2014 Jul 4;63(26):576; ppublish
Place of Publication
United States
ISSN/ISBN
1545-861X; 0149-2195
Accession Number
PMID: 24964880
Language
eng
SubFile
Journal Article; IM
DOI
mm6325a3 [pii]
Output Language
Unknown(0)
PMID
24964880
Abstract
Despite significant declines in cigarette smoking among U.S. adults over the past five decades, progress has slowed in recent years, and the prevalence of use of other tobacco products such as cigars and smokeless tobacco has not changed. Additionally, the prevalence of use of emerging products, including electronic cigarettes (e-cigarettes), has rapidly increased. This report provides the most recent national estimates of tobacco use among adults aged >/=18 years, using data from the 2012-2013 National Adult Tobacco Survey (NATS). The findings indicate that 21.3% of U.S. adults used a tobacco product every day or some days, and 25.2% used a tobacco product every day, some days, or rarely. Population-level interventions focused on the diversity of tobacco product use, including tobacco price increases, high-impact antitobacco mass media campaigns, comprehensive smoke-free laws, and enhanced access to help quitting, in conjunction with Food and Drug Administration (FDA) regulation of tobacco products, are critical to reducing tobacco-related diseases and deaths in the United States.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Agaku,I.T., King,B.A., Husten,C.G., Bunnell,R., Ambrose,B.K., Hu,S.S., Holder-Hayes,E., Day,H.R., Centers for Disease Control and Prevention (CDC)
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Ebola viral disease outbreak--West Africa, 2014 2014
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
MMWR.Morbidity and mortality weekly report
Periodical, Abbrev.
MMWR Morb.Mortal.Wkly.Rep.
Pub Date Free Form
27-Jun
Volume
63
Issue
25
Start Page
548
Other Pages
551
Notes
LR: 20150420; JID: 7802429; CIN: Ann Emerg Med. 2015 Jan;65(1):114-5. PMID: 25671238; ppublish
Place of Publication
United States
ISSN/ISBN
1545-861X; 0149-2195
Accession Number
PMID: 24964881
Language
eng
SubFile
Journal Article; IM
DOI
mm6325a4 [pii]
Output Language
Unknown(0)
PMID
24964881
Abstract
On March 21, 2014, the Guinea Ministry of Health reported the outbreak of an illness characterized by fever, severe diarrhea, vomiting, and a high case-fatality rate (59%) among 49 persons. Specimens from 15 of 20 persons tested at Institut Pasteur in Lyon, France, were positive for an Ebola virus by polymerase chain reaction. Viral sequencing identified Ebola virus (species Zaire ebolavirus), one of five viruses in the genus Ebolavirus, as the cause. Cases of Ebola viral disease (EVD) were initially reported in three southeastern districts (Gueckedou, Macenta, and Kissidougou) of Guinea and in the capital city of Conakry. By March 30, cases had been reported in Foya district in neighboring Liberia (1), and in May, the first cases identified in Sierra Leone were reported. As of June 18, the outbreak was the largest EVD outbreak ever documented, with a combined total of 528 cases (including laboratory-confirmed, probable, and suspected cases) and 337 deaths (case-fatality rate = 64%) reported in the three countries. The largest previous outbreak occurred in Uganda during 2000-2001, when 425 cases were reported with 224 deaths (case-fatality rate = 53%). The current outbreak also represents the first outbreak of EVD in West Africa (a single case caused by Tai Forest virus was reported in Cote d'Ivoire in 1994 [3]) and marks the first time that Ebola virus transmission has been reported in a capital city.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Dixon,M.G., Schafer,I.J., Centers for Disease Control and Prevention (CDC)
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Effect of nonsurgical periodontal therapy verses oral hygiene instructions on type 2 diabetes subjects with chronic periodontitis: a randomised clinical trial 2014 Department of Restorative Dentistry, Faculty of Dentistry, University of Malaya, 50603 Kuala Lumpur, Malaysia. rathna@um.edu.my.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
BMC oral health
Periodical, Abbrev.
BMC Oral Health.
Pub Date Free Form
25-Jun
Volume
14
Issue
Start Page
79
Other Pages
6831-14-79
Notes
LR: 20150805; ClinicalTrials.gov/NCT01951547; JID: 101088684; 0 (Anti-Infective Agents, Local); 0 (Hemoglobin A, Glycosylated); 0 (Mouthwashes); 9007-41-4 (C-Reactive Protein); R4KO0DY52L (Chlorhexidine); OID: NLM: PMC4082680; 2014/03/12 [received]; 2014/
Place of Publication
England
ISSN/ISBN
1472-6831; 1472-6831
Accession Number
PMID: 24965218
Language
eng
SubFile
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; D; IM
DOI
10.1186/1472-6831-14-79 [doi]
Output Language
Unknown(0)
PMID
24965218
Abstract
BACKGROUND: 40 subjects with type 2 diabetes and moderate to severe CP were randomly distributed to groups receiving either NSPT or OHI. Periodontal parameters, glycosylated haemoglobin (HbA1c) and high-sensitivity C-reactive protein (hs-CRP) were evaluated at baseline, 2- and 3-months intervals. METHODS: 40 subjects with type 2 diabetes and moderate to severe CP were randomly distributed to groups receiving either NSPT or OHI. Periodontal parameters, glycosylated haemoglobin (HbA1c) and high-sensitivity C-reactive protein (hs-CRP) were evaluated at baseline, 2- and 3-months intervals. RESULTS: 15 subjects from NSPT group and 17 from OHI group completed the study. The difference in plaque index (PI) between NSPT and OHI groups were significant at 2 months recall (p = 0.013). There was no significant difference between NSPT and OHI group for all other clinical periodontal parameters, HbA1c and CRP levels. At 3 months post-therapy, periodontal parameters improved significantly in both groups with sites with probing pocket depth (PPD) /= 50% reduction in PPD showed significant reductions of HbA1c and hs-CRP levels (p = 0.004 and p = 0.012). CONCLUSION: NSPT significantly reduced PI at 2 months post-therapy as compared to OHI. Both NSPT and OHI demonstrated improvements in other clinical parameters as well as HbA1c and CRP levels. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01951547.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Raman,R.P., Taiyeb-Ali,T.B., Chan,S.P., Chinna,K., Vaithilingam,R.D.
Original/Translated Title
URL
Date of Electronic
20140625
PMCID
PMC4082680
Editors